UBS Group
MRT

UBS Group’s MedEquities Realty Trust, Inc. MRT Stock Holding History

UBS Group’s Portfolio MRT Stock Details MRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,268
Closed -$14K – 8451
2019
Q1 		$14K Sell
1,268
-27,241
-96% -$295K ﹤0.01% 6621
2018
Q4 		$195K Buy
28,509
+3,630
+15% +$28.5K ﹤0.01% 4975
2018
Q3 		$242K Buy
24,879
+1,736
+8% +$18.4K ﹤0.01% 4923
2018
Q2 		$255K Sell
23,143
-91
-0.4% -$939 ﹤0.01% 4781
2018
Q1 		$244K Buy
23,234
+7,978
+52% +$84.8K ﹤0.01% 4657
2017
Q4 		$171K Buy
15,256
+6,103
+67% +$69.1K ﹤0.01% 5027
2017
Q3 		$108K Sell
9,153
-186
-2% -$2.21K ﹤0.01% 5271
2017
Q2 		$118K Sell
9,339
-4,165
-31% -$49.9K ﹤0.01% 5073
2017
Q1 		$151K Buy
13,504
+8,847
+190% +$98.7K ﹤0.01% 4819
2016
Q4 		$52K Buy
+4,657
New +$52K ﹤0.01% 5806

UBS Group's MRT Position: Q2 2019 in Review

UBS Group sold out of MedEquities Realty Trust, Inc. (MRT) in Q2 2019, closing a stake of 1,268 shares — an estimated $14K sold.

UBS Group first reported a position in MRT in Q4 2016 and held it in 10 quarters. The position peaked at $255K in Q2 2018. 0 funds tracked by Wall St. Rank hold MRT as of Q2 2019.

  • UBS Group reported no remaining MedEquities Realty Trust, Inc. position as of Q2 2019 after selling out during the quarter.
  • UBS Group sold 1,268 MedEquities Realty Trust, Inc. shares in Q2 2019, an estimated $14K.
  • UBS Group first reported a position in MedEquities Realty Trust, Inc. in Q4 2016 and held it in 10 quarters.
  • UBS Group's MedEquities Realty Trust, Inc. position peaked at $255K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q2 2019.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.